ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Privacy Biostatistician - Risk Analytics at Truveta - ApplyBlast

Senior Privacy Biostatistician - Risk Analytics

Truveta

9 days ago

3.7 on Glassdoor

Remote

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Truveta is seeking a Senior Privacy Biostatistician to lead statistical disclosure control strategies for complex health datasets, including structured, imaging, clinical notes, and genomic data. The role involves independently determining re-identification risks under HIPAA, mentoring junior staff, and collaborating with clinical informatics and legal teams to ensure data privacy and security. This position requires a strong track record in statistical methods applied to patient health information and the ability to produce audit-ready documentation.

Responsibilities

Lead statistical disclosure control strategy for complex health datasets
Sign Expert Determinations under HIPAA to verify very small re-identification risk
Mentor junior privacy biostatisticians and set methodological standards

Skills

Qualifications

Master's degree in biostatistics, statistics, epidemiology, or related quantitative fieldPhD

About Truveta

truveta.com

Headquarters

Seattle, Washington, United States

Company Size

201-500 employees

Founded

2020

View Profile

Truveta is a healthcare data company that aggregates de‑identified electronic health record data from member health systems to enable faster clinical insights and research. It offers a secure, privacy‑focused analytics platform and curated datasets so researchers, life‑science companies, public‑health agencies, and clinicians can run population‑level queries, real‑world evidence studies, and build/validate AI models. Truveta emphasizes strong governance and HIPAA‑aligned de‑identification through partnerships with participating health systems. Organizations use its tools to accelerate drug development, surveillance, care‑quality improvements, and evidence generation across diseases and treatments.